En Es

Industry News

Handheld Scanners Market to Reach USD 725 Million by 2027

By Medimaging International staff writers
16 Oct 2017

Image: The Vscan portable ultrasound scanner (Photo courtesy of GE Healthcare).The global handheld ultrasound scanners market is projected to grow at a robust CAGR of 8.8% from around USD 311 million in 2017 to about USD 725 million by 2027 end, driven mainly by the increasing use of handheld ultrasound scanners among non-radiologists and modernization in healthcare, coupled with high investment in research and development (R&D).

These are the latest findings of Future Market Insights (Valley Cottage, NY, USA), a market intelligence and consulting firm.

Some of the key growth drivers of the global handheld ultrasound scanners market are technological advancements, innovations and developments in medical imaging devices and ultrasound scanning, increasing use of handheld ultrasound scanners in emergency medical services, rising healthcare expenditure, changing healthcare pattern, and rising prevalence of chronic disorders. The market growth is also being fueled by increasing number of medical device manufacturers, rising product penetration due to the adoption of distribution and licensing agreements by various players, benefits of international trade agreements, higher imports of imaging diagnostics systems, and rising focus of healthcare companies on inorganic growth. However, limited R&D in some areas, rising consumption tax, shortage of skilled professionals, non-standardized product pricing and sale of counterfeit medical devices are likely to act as constraints to the growth of the global handheld ultrasound scanners market.

By display type, the color display segment is projected to record the highest growth during the forecast period with a CAGR of 9.5% to reach a market value of about USD 460 million by the end of 2027. By modality type, the wireless scanners segment is poised to record the highest CAGR of 10.1% during 2017-2027, while the wired scanners segment is expected to register the highest market value by the end of the forecast period.

By end-user category, the hospitals segment has been dominating the handheld ultrasound scanners market since 2012 and is expected to remain the largest segment in terms of market value. The hospitals end-user segment is projected to grow at the highest CAGR of 9.3% throughout the forecast period of 2017-2027 to reach USD 280 million. The diagnostic centers segment has been gaining traction since 2016 and is the second-fastest growing end-user segment of the handheld ultrasound scanners market. The use of handheld ultrasound scanners among ambulatory surgical centers (ASCs) has also picked up recently. As a result, the ASCs end-user segment is also expected to record a high growth rate during the forecast period and achieve a significant market value.

By region, North America is expected to dominate the global handheld ultrasound scanners market and is projected to grow at the highest CAGR of 9.5% throughout the forecast period to surpass USD 330 million by the end of 2027. The diagnostic centers segment is expected to be the fastest growing segment in North America, followed by the hospitals segment. In Western Europe, the hospitals segment leads the market and is projected to achieve a market valuation of USD 48.3 million by 2027 end. After North America, Asia Pacific (excluding Japan), is expected to achieve the second-highest market valuation during 2017-2027, surpassing even the Western and Eastern European regions. Japan is projected to record the second-highest growth rate in the coming years owing to favorable government regulations and increased developments in its healthcare domain. The hospitals segment is growing at the fastest pace in Japan as compared to other regions, with a projected CAGR of 9.9% during 2017-2027. However, the adoption of handheld ultrasound scanners in hospitals, ASCs and diagnostic centers is comparatively lower in the Middle East and Africa region, resulting in lower revenues from the region by 2027.

Related Links:
Future Market Insights

E-mail Print
FaceBook Twitter Google+ Linked in

GE Healthcare

GE Healthcare provides medical imaging and information technologies, medical diagnostics, patient monitoring systems, drug discovery, biopharmaceutical manufacturing technologies, performance improvement and performance solutions services. The company’s product areas include anesthesia delivery, diagnostic ECG, mammography, radiography, surgical imaging, maternal-infant care and clinical consumables.
More info

More articles about GE Healthcare

29 Apr 2022
GE Healthcare and Medtronic Collaborate to Improve Product Access for ASCs and OBLs
GE Healthcare (Chicago, IL, USA) and Medtronic (Doral, FL, USA) have entered into a collaboration focused on the unique needs and demand for care at Ambulatory Surgery Centers (ASCs) and Office Based Labs (OBLs) that will allow customers to access extensive product portfolios, financial solutions, and exceptional service.
Read More
23 Dec 2021
GE Healthcare Completes Acquisition of BK Medical to Expand Its Ultrasound Business
GE Healthcare (Chicago, IL, USA) has completed its previously announced acquisition of BK Medical (Peabody, MA, USA; www.bkmedical.com) in a deal that would expand its ultrasound business from diagnostics into surgical and therapeutic interventions.
Read More
13 Nov 2021
GE Healthcare to be Spun Off in 2023 to Create Pure-Play Company at Center of Precision Health
General Electric (GE; Boston, MA, USA) plans to pursue a tax-free spin-off of GE Healthcare, creating a pure-play company at the center of precision health in early 2023.
Read More
30 Sep 2021
GE Healthcare Acquires BK Medical to Expand Ultrasound Portfolio into Surgical Visualization
GE Healthcare (Chicago, IL, USA) has entered into an agreement to acquire BK Medical (Peabody, MA, USA) in a deal that is expected to create value by further strengthening BK, including through significant synergies with the benefit of GE’s technology and commercial scale.
Read More
26 Jul 2021
GE Healthcare Backs Development of Innovative Total-Body PET/CT Scanner for Simultaneous Whole-Body Imaging
GE Healthcare (Chicago, IL, USA) is backing a collaboration among Quibim (Valenciana, Spain), Full Body Insight, and Oncovision (Valenciana, Spain) to build an innovative total-body PET/CT scanner for simultaneous whole-body imaging.
Read More
30 Jan 2020
Study Finds Most Healthcare Institutions Plan to Use AI and Develop Own AI Algorithm
 A new study of healthcare professionals has revealed that Artificial Intelligence (AI) is widely expected to drive important benefits across the health system, from increasing efficiency to improving patient outcomes, but may also be the key to making healthcare more human. AI’s benefits range from increasing the amount of time clinicians can spend with patients and on cross-care team collaboration to enhancing the ability to deliver preventative care.
Read More
26 Sep 2019
GE Healthcare and Affibody Collaborate to Develop PET Imaging Tracers
GE Healthcare and Affibody AB have entered into a strategic collaboration to develop and commercialize Affibody-based PET imaging tracers, with initial focus on HER2 and PD-L1.
Read More
22 Aug 2019
GE Healthcare Partners with Fujitsu to Develop AI for Spotting Brain Aneurysms
GE Healthcare has entered into a research collaboration with Fujitsu Australia to diagnose and monitor brain aneurysms on scans faster and more efficiently by using artificial intelligence.
Read More

Additional news

27 Jun 2022
Robot-Assisted Surgical Devices Market Driven by Increased Demand for Patient-Specific Surgeries
Given the growing incidence of lifestyle diseases and demand for affordable healthcare, effective surgery using robotic devices can result in a decline in treatment costs and drive the growth of the global robot-assisted surgical devices (RASD) market.
Read More
24 Jun 2022
Fujirebio Acquires ADx NeuroSciences to Speed Development of Neurodegenerative Diseases Diagnostic Tests
Fujirebio Holdings, Inc. (Tokyo, Japan) has announced the acquisition of ADx NeuroSciences (Gent, Belgium) for EUR 40 million in a deal that is expected to close in July 2022, pending the satisfaction of customary closing conditions.
Read More
23 Jun 2022
Hospital Microbiology Testing Market Driven by Increasing Prevalence of Chronic Diseases
Rising medical expenditure as well as the presence of well-established modern healthcare infrastructure in various developed as well as developing regions is fueling the growth of the global hospital microbiology testing market.
Read More
22 Jun 2022
Global Minimally Invasive Surgery (MIS) Market to Surpass USD 325 Billion by 2031
The global MIS market is projected to surpass USD 325 billion by 2031, driven by growing patient awareness of the advantages of MIS over open surgeries, continuous innovation in surgical robots, and constant advancements in other MIS-associated technologies during the 2022-2031 forecast period.
Read More
21 Jun 2022
Medix Biochemica Acquires IVD Raw Materials Producer Bioresource Technology
Medix Biochemica (Espoo, Finland) has acquired 100% of the shares of Bioresource Technology (BRT, Weston, FL, USA) to broaden its base matrix capabilities and further strengthen its local presence in the US market.
Read More
21 Jun 2022
Global Bedside Testing Market to Witness Promising Prospects in Critical Care
Point-of-care or point-of-use diagnostics, also known as bedside testing, has gained increased prominence in analytical testing over the past few years as it provides clinically relevant information without the need for a dedicated laboratory.
Read More
20 Jun 2022
Global Sepsis Diagnostics Market Driven by Rising Hospital-Acquired Illnesses
The global sepsis diagnostics market is expected to grow at a CAGR of 8.3% during the period 2022-2028 to reach almost USD 0.88 billion by 2028, driven by a rise in the number of hospital-acquired illnesses and the rapidly growing molecular diagnostics market, although the high cost of automated diagnostic instruments could hamper market growth.
Read More
14 Jun 2022
BD Partners with Mayo Clinic Platform for Access to World's Largest Collection of Clinical Data
Becton, Dickinson and Company (BD, Franklin Lakes, NJ, USA) has entered into a collaboration with Mayo Clinic Platform (Rochester, MN, USA) to access de-identified patient data from Mayo Clinic Platform_Discover.
Read More
14 Jun 2022
Quidel Partners with Global Lyme Alliance, Leads in Lyme Disease Testing
Quidel Corporation (San Diego, CA, USA) is joining forces with Global Lyme Alliance (Stamford, CT, USA) to heighten public awareness around Lyme disease during Lyme Disease Awareness Month (in May) and beyond.
Read More
Copyright © 2000-2022 TradeMed.com. All rights reserved. | Terms And Conditions